Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs dexamethasone + droperidol for prevention of PONV in gynecological day surgery under ciprofol-alfentanil anesthesia
ChiCTR2600119674Phase 4Not yet recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing dexamethasone + droperidol with Control: dexamethasone + saline (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting within 24 hours. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dexamethasonedroperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600119674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119674.